(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine

(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine Suppliers list
Company Name: Hangzhou ICH Biofarm Co., Ltd
Tel: +86-0571-28186870; +undefined8613073685410
Email: sales@ichemie.com
Products Intro: Product Name:(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine
CAS:608141-42-0
Purity:99% Package:1kg;|5kg;|10kg
Company Name: Hebei Ganmiao New material Technology Co., LTD
Tel: +86-17332992504
Email: sales8@hbganmiao.com
Products Intro: Product Name:(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine
CAS:608141-42-0
Purity:99.9% Package:1kg;10USD|10kg;9USD|100kg;7USD
Company Name: ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
Tel: +86-13017695106 +86-13676922317
Email: jiuyitime@fdachem.com
Products Intro: Product Name:(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine
CAS:608141-42-0
Purity:99% Package:100kg;2USD|10kg;4USD|1kg;6USD
Company Name: Hefei Lbao Physical & Chemical Science Co.,Ltd
Tel: +15184799099
Email: lbaochemicals@gmail.com
Products Intro: Product Name:(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine
CAS:608141-42-0
Purity:98% Package:1kg
Company Name: Beijing Cooperate Pharmaceutical Co.,Ltd
Tel: 010-60279497
Email: sales01@cooperate-pharm.com
Products Intro: Product Name:(alphaS)-3-Ethoxy-4-methoxy-alpha-[(methylsulfonyl)methyl]-benzenemethanamine
CAS:608141-42-0
Purity:98% Package:100G;1KG;5KG;10KG;25KG;50KG;100KG

(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine manufacturers

(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine Basic information
Product Name:(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine
Synonyms:(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine;(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine;(S)-2-(3-ethoxy-4-Methoxyphenyl)-1-(Methylsulphonyl)-eth-1-ylaMine;Apremilast Intermediate II;(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine;1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethylamine-N- acetyl –L-Leucine salt;(1S)-1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethylamine;(S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)-eth-2-ylamine
CAS:608141-42-0
MF:C12H19NO4S
MW:273.35
EINECS:807-236-0
Product Categories:apremilast intermediates
Mol File:608141-42-0.mol
(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine Structure
(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine Chemical Properties
Melting point 106-108oC
Boiling point 469.6±45.0 °C(Predicted)
density 1.195±0.06 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,Room temperature
solubility Chloroform (Slightly), Methanol (Slightly)
pka6.84±0.10(Predicted)
form Solid
color White to Off-White
Major Applicationpharmaceutical small molecule
InChIInChI=1/C12H19NO4S/c1-4-17-12-7-9(5-6-11(12)16-2)10(13)8-18(3,14)15/h5-7,10H,4,8,13H2,1-3H3/t10-/s3
InChIKeyBXUJVINGXQGNFD-JQHDBZEONA-N
SMILES[C@@H](C1C=CC(OC)=C(OCC)C=1)(N)CS(=O)(=O)C |&1:0,r|
Safety Information
WGK Germany WGK 3
HS Code 2930909899
Storage Class11 - Combustible Solids
Hazard ClassificationsAcute Tox. 4 Oral
Skin Irrit. 2
MSDS Information
(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine Usage And Synthesis
Chemical PropertiesAPREMILAST intermediate is slightly soluble in dichloromethane and soluble in methanol. It is mainly used to synthesize APREMILAST. In addition, it can also regulate intracellular pro-inflammatory and anti-inflammatory factor effects through specificity for cyclic adenosine monophosphate (c AMP), which increases intracellular cAMP levels.
Uses(1S)-1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethylamine is an Apremilast (A729700) intermediate. Apremilast, an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis.
Synthesis
1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine

1450657-31-4

(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine

608141-42-0

The general procedure for the synthesis of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine from the compound (CAS: 1450657-31-4) was as follows: bis(1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate (36 mg, 0.074 mmol) and (S)-1-[(R)-2- ( diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine (40 mg, 0.074 mmol) were dissolved in 25 mL of 2,2,2-trifluoroethanol. Subsequently, 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine (2.0 g, 7.4 mmol) was added to this solution. The reaction mixture was heated to 50 °C and hydrogenated under hydrogen pressure of 90 psig. After 18 h, the mixture was cooled to room temperature and removed from the hydrogenation unit. The solvent was removed by rotary evaporation and the residue was purified by chromatography on a C18 reversed-phase column using a water-acetonitrile gradient elution. The fraction containing the target product was collected and concentrated to about 150 mL. saturated brine (20 mL) was added to the concentrate and subsequently extracted with ethyl acetate (3 x 50 mL). The organic layers were combined, dried over anhydrous magnesium sulfate, filtered and concentrated to give a white crystalline solid product (1.4 g, 70% yield). The product was analyzed by non-chiral HPLC (Hypersil BDSC8, 5.0 μm, 250 × 4.6 mm, 1.5 mL/min, 278 nm, 90/10 to 80/20 0.1% TFA aqueous solution/methanol gradient elution for 10 min, followed by a gradient up to 10/90 0.1% TFA aqueous solution/methanol for the next 15 min). Retention time was 9.11 min (99.6% purity); chiral HPLC (Chiralpak AD-H 5.0 μm Daicel, 250 × 4.6 mm, 1.0 mL/min, 280 nm, 70:30:0.1 heptane-isopropanol-diethylamine) analyzed with retention times of 7.32 min (97.5%) and 8.26 min ( 2.47%).1H NMR (DMSO-d6) δ 1.32 (t, J = 7.0 Hz, 3H), 2.08 (s, 2H), 2.96 (s, 3H), 3.23 (dd, J = 3.6, 14.4 Hz, 1H), 3.41 (dd, J = 9.4, 14.4 Hz, 1H), 3.73 (s, 3H), 4.02 (q , J = 7.0 Hz, 2H), 4.26 (dd, J = 3.7, 9.3 Hz, 1H), 6.89 (s, 2H), 7.02 (s, 1H); 13C NMR (DMSO-d6) δ 14.77, 41.98, 50.89, 55.54, 62.03, 63.68, 111.48, 111.77, 118.36, 137.30, 147.93, 148.09.

References[1] Patent: US2014/81032, 2014, A1. Location in patent: Paragraph 0318; 0319
[2] Patent: US2013/217919, 2013, A1. Location in patent: Paragraph 0280
[3] Patent: WO2016/199031, 2016, A1
Tag:(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine(608141-42-0) Related Product Information
1,3-Dioxo-2-isoindolineaceticacid 3,5-Cyclohexadiene-1,2-dione, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]- Apremilast 1,2-Benzenedicarboxylicacid,3-(hydroxyamino)-(9CI) Apremilast Impurity 3 3-oxo-1,3-dihydro-benzo[c]isoxazole-4-carboxylic acid 6H,12H-Indazolo[2,1-a]indazole-1,7-dicarboxylic acid, 6,12-dioxo- (S)-N-(2-(1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide Apremilast APST-ZA (R)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide (S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide Apremilast Impurity 4 2-CHLORO-4'-HYDROXYACETOPHENONE (S)-1-(4-chloro-3-fluorophenyl)ethane-1,2-diol (S)-4-Bromo-alpha-methylbenzyl alcohol (S)-1-(3-bromo-2-methoxyphenyl)ethan-1-ol 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl) ethanone